FindTrial
Sign In

Development of Patient Education Booklet on Ovarian Cancer

Preparation, Validation and User-Readability Assessment of Patient Education Booklet on Ovarian Cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/071317
Enrollment
45
Registered
2024-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

Control Intervention1: NIL: NIL

Sponsors

NGSM Institute of Pharmaceutical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged above 18 years, diagnosed with ovarian cancer and undergoing chemotherapy, patients who can read and understand either English or Kannada languages, patients who gave their consent for the study.

Exclusion criteria

Exclusion criteria: Patients who are critically ill.

Design outcomes

Primary

MeasureTime frame
The study is expected to convey the relevance of using printed materials such as validated patient education booklets with standard readability in educating the ovarian cancer patient.Timepoint: 8 months.—

Secondary

MeasureTime frame
The study is expected to convey the relevance of using printed materials such as validated patient education booklets with standard readability in educating the ovarian cancer patient.Timepoint: 8 months.—

Countries

India

Contacts

Public ContactDr Krishna Sharan

NGSM Institute of Pharmaceutical Sciences

nandakumarvtkv@gmail.com9633023062

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026